CCMH
ANTH

Cornerstone Capital Management Holdings’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,900
Closed -$108K – 1610
2015
Q4 		$108K Buy
2,900
+1,987
+218% +$87.7K ﹤0.01% 1300
2015
Q3 		$44K Buy
+913
New +$63.8K ﹤0.01% 1414

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Cornerstone Capital Management Holdings's ANTH Position: Q1 2016 in Review

Cornerstone Capital Management Holdings sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2016, closing a stake of 2,900 shares — an estimated $108K sold.

Cornerstone Capital Management Holdings first reported a position in ANTH in Q3 2015 and held it in 2 quarters. The position peaked at $108K in Q4 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q1 2016.

  • Cornerstone Capital Management Holdings reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 2,900 Anthera Pharmaceuticals, Inc. shares in Q1 2016, an estimated $108K.
  • Cornerstone Capital Management Holdings first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2015 and held it in 2 quarters.
  • Cornerstone Capital Management Holdings's Anthera Pharmaceuticals, Inc. position peaked at $108K in Q4 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2016, filed 11 May 2016.